H1B Salary Data

Home › Employers › CHRISTUS Health Central Louisiana

CHRISTUS Health Central Louisiana: H-1B salaries and sponsorship

CHRISTUS Health Central Louisiana filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $56,160.

Applications (LCAs)3
Certified3
Employer addressIrving, TX
H-1B dependent employerNo
Median offered salary$56,160
Middle half of salaries$56,160–$56,160
10th–90th percentile$56,160–$56,160

Does CHRISTUS Health Central Louisiana sponsor H-1B visas?

CHRISTUS Health Central Louisiana filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Dec 20, 2023. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Clinical Laboratory Scientist/Medical Technologist3$56,160

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20243$56,160

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Clinical Laboratory Scientist/Medical Technologist$56,160
Level IV
Alexandria, LADec 20, 2023Feb 26, 2024Certified
Clinical Laboratory Scientist/Medical Technologist$56,160
Level IV
Alexandria, LANov 10, 2023May 8, 2024Certified
Clinical Laboratory Scientist/Medical Technologist$56,160
Level IV
Alexandria, LANov 10, 2023May 7, 2024Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).